Tiejun Li

Vice General Manager Asymchem Inc.

Tiejun Li is a Vice General Manager at AsymBio. He is a seasoned professional in the biopharmaceutical industry, bringing extensive expertise in drug substance and drug product development, manufacturing operations, and CMC regulatory submissions. His career is marked by a strong track record of leading organizations and demonstrating exceptional leadership in advancing drug products from development through to commercial scale-up.

Tiejun excels in building and mentoring high-performance teams, fostering a culture of excellence and continuous improvement. He has a strong ability to manage CDMOs and CROs, negotiate contracts, and oversee project execution, all crucial in supporting clinical trials and regulatory submissions. His comprehensive skill set and extensive experience enable him to drive projects to successful completion while maintaining the highest standards of quality and compliance.

Seminars

Tuesday 24th February 2026
Accelerating the Development of Next Generation Bioconjugate Drugs Through an Integrated Platform
3:00 pm
  • Overviewing the challenges in bioconjugation CMC development for novel NDCs
  • Case study examples: Exploring strategies and fit for purpose solutions for complex bioconjugation processes development
  • Overviewing AsymChem/AsymBio’s integrated capabilities in NDC CDMO services
Tiejun Li Vice General Manager AsymBio